NO20004431L - Glysintransportinhibitorer - Google Patents

Glysintransportinhibitorer

Info

Publication number
NO20004431L
NO20004431L NO20004431A NO20004431A NO20004431L NO 20004431 L NO20004431 L NO 20004431L NO 20004431 A NO20004431 A NO 20004431A NO 20004431 A NO20004431 A NO 20004431A NO 20004431 L NO20004431 L NO 20004431L
Authority
NO
Norway
Prior art keywords
epsi
epilepsy
piperazinyl
piperidinyl
fluorophenyl
Prior art date
Application number
NO20004431A
Other languages
Norwegian (no)
Other versions
NO20004431D0 (en
Inventor
Walter Herman Maria Lou Luyten
Frans Eduard Janssens
Ludo Edmond Josephine Kennis
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO20004431D0 publication Critical patent/NO20004431D0/en
Publication of NO20004431L publication Critical patent/NO20004431L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Den foreliggende oppfinnelse vedrører anvendelsen av glysintransportinhiberende 4,4-bis (4-fluorfenyl)butyl]-1-(piperazinyl og piperidinyl)-derivater ved fremstillingen av medikamenter for å behandle forstyrrelser i det sentrale og perifere nervesystem, spesielt psykoser, smerte, epil-epsi, nevrodegenerative sykdommer (Alzheimers sykdom),. slag, hodetraume, multippel sklerose og lignende. Opp-finnelsen omfatter videre nye forbindelser, deres frem-stilling og deres farmasøytisk former.The present invention relates to the use of glycine transport inhibiting 4,4-bis (4-fluorophenyl) butyl] -1- (piperazinyl and piperidinyl) derivatives in the manufacture of medicaments for the treatment of disorders of the central and peripheral nervous system, in particular psychoses, pain, epilepsy. -epsi, neurodegenerative diseases (Alzheimer's disease) ,. stroke, head trauma, multiple sclerosis and the like. The invention further encompasses novel compounds, their preparation and their pharmaceutical forms.

NO20004431A 1998-03-06 2000-09-05 Glysintransportinhibitorer NO20004431L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98200701 1998-03-06
PCT/EP1999/001309 WO1999044596A2 (en) 1998-03-06 1999-02-26 Glycine transport inhibitors

Publications (2)

Publication Number Publication Date
NO20004431D0 NO20004431D0 (en) 2000-09-05
NO20004431L true NO20004431L (en) 2000-10-30

Family

ID=8233444

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004431A NO20004431L (en) 1998-03-06 2000-09-05 Glysintransportinhibitorer

Country Status (17)

Country Link
EP (1) EP1059922A2 (en)
JP (1) JP2002505277A (en)
KR (1) KR20010032968A (en)
CN (1) CN1292698A (en)
AU (1) AU3408999A (en)
BG (1) BG104685A (en)
BR (1) BR9907951A (en)
CA (1) CA2322164A1 (en)
EE (1) EE200000482A (en)
HR (1) HRP20000523A2 (en)
HU (1) HUP0101048A2 (en)
IL (1) IL138228A0 (en)
NO (1) NO20004431L (en)
PL (1) PL343435A1 (en)
SK (1) SK13082000A3 (en)
TR (1) TR200002567T2 (en)
WO (1) WO1999044596A2 (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1400519B1 (en) * 1999-06-28 2007-03-07 Janssen Pharmaceutica N.V. Respiratory syncytial virus replication inhibitors
UA73749C2 (en) * 1999-11-01 2005-09-15 Diarylenines
WO2001081308A2 (en) * 2000-04-20 2001-11-01 Nps Allelix Corp. Aminopiperidines for use as glyt-1 inhibitors
DE10040016A1 (en) * 2000-08-16 2002-02-28 Boehringer Ingelheim Pharma Novel beta-amyloid inhibitors, process for their preparation and their use as pharmaceuticals
CA2422198A1 (en) 2000-09-08 2002-03-14 Gliatech, Inc. Substituted hydrazine derivatives
US6946474B2 (en) 2000-09-14 2005-09-20 Merck & Co., Inc. Nitrogen-containing compounds and their use as glycine transport inhibitors
AR032653A1 (en) 2001-02-09 2003-11-19 Telik Inc HYPERCYCLIC INHIBITORS OF THE GLICINE TRANSPORTER 2 PHARMACEUTICAL COMPOSITIONS, USE AND METHODS.
US7030150B2 (en) 2001-05-11 2006-04-18 Trimeris, Inc. Benzimidazole compounds and antiviral uses thereof
ATE374610T1 (en) * 2003-09-09 2007-10-15 Hoffmann La Roche 1-(2-AMINO-BENZOYL)-PIPERAZINE DERIVATIVES AS GLYCINE ABSORPTION INHIBITORS FOR THE TREATMENT OF PSYCHOSIS
AU2004269892B2 (en) 2003-09-09 2010-03-11 F. Hoffmann-La Roche Ag 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses
WO2005058885A2 (en) * 2003-12-18 2005-06-30 Glaxo Group Limited Piperidine derivatives and their use as glycine transporter inhibitors
TW200630337A (en) 2004-10-14 2006-09-01 Euro Celtique Sa Piperidinyl compounds and the use thereof
RU2395502C2 (en) * 2004-12-09 2010-07-27 Ф.Хоффманн-Ля Рош Аг Phenyl-piperazine methanone derivatives
DE602005019465D1 (en) 2004-12-15 2010-04-01 Hoffmann La Roche BI- AND TRICYCLIC SUBSTITUTED PHENYL-METHANONE AS INHIBITORS OF GLYCIN-I (GLYT-1) TRANSPORTERS FOR THE TREATMENT OF ALZHEIMER DISEASE
GB0428233D0 (en) * 2004-12-23 2005-01-26 Glaxo Group Ltd Compounds
PE20061156A1 (en) 2004-12-23 2006-12-16 Glaxo Group Ltd BENZAMIDE DERIVATIVES AS INHIBITING AGENTS OF THE GLYCINE TRANSPORTER
US7485637B2 (en) 2005-01-04 2009-02-03 Hoffmann-La Roche Inc. Benzoyl-tetrahydropiperidine derivatives
CA2593453A1 (en) * 2005-01-06 2006-07-13 F. Hoffmann-La Roche Ag Sulfanyl substituted phenyl methanones as glycine transporter 1 (glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders
AU2005324024B2 (en) * 2005-01-07 2011-02-17 F. Hoffmann-La Roche Ag [4-(Heteroaryl) piperazin-1-yl]-(2,5-substituted -phenyl)methanone derivatives as glycine transporter 1 (GlyT-1) inhibitors for the treatment of neurological and neuropsychiatric disorders
JP2008527016A (en) 2005-01-18 2008-07-24 エフ．ホフマン−ラ ロシュ アーゲー 2,5-Disubstituted phenylmethanone derivatives as glycine transporter 1 (GlyT-1) inhibitors for the treatment of neurological and neuropsychiatric diseases
KR100915472B1 (en) 2005-01-26 2009-09-03 에프. 호프만-라 로슈 아게 Phenyl methanone derivatives and their use as glycine transporter 1 inhibitors
UA91536C2 (en) * 2005-02-07 2010-08-10 Ф. Хоффманн-Ля Рош Аг Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1
CN100341871C (en) * 2005-06-03 2007-10-10 复旦大学 Organic sulfur compound containing piperidine structure, its preparation and use
US8247442B2 (en) 2006-03-29 2012-08-21 Purdue Pharma L.P. Benzenesulfonamide compounds and their use
TW200812963A (en) 2006-04-13 2008-03-16 Euro Celtique Sa Benzenesulfonamide compounds and the use thereof
TW200815353A (en) 2006-04-13 2008-04-01 Euro Celtique Sa Benzenesulfonamide compounds and their use
PT2079485E (en) * 2006-11-01 2012-08-13 Purdue Pharma Lp Phenylpropionamide compounds and the use thereof
FR2910320B1 (en) * 2006-12-21 2009-02-13 Galderma Res & Dev S N C Snc EMULSION COMPRISING AT LEAST ONE RETINOID AND BENZOLE PEROXIDE
FR2910321B1 (en) 2006-12-21 2009-07-10 Galderma Res & Dev S N C Snc CREAM GEL COMPRISING AT LEAST ONE RETINOID AND BENZOLE PEROXIDE
US8399486B2 (en) 2007-04-09 2013-03-19 Purdue Pharma L.P. Benzenesulfonyl compounds and the use thereof
US8765736B2 (en) 2007-09-28 2014-07-01 Purdue Pharma L.P. Benzenesulfonamide compounds and the use thereof
WO2009075857A2 (en) * 2007-12-12 2009-06-18 Amgen Inc. Glycine transporter-1 inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1140119A (en) * 1978-04-03 1983-01-25 Joseph Torremans N-heterocyclyl-4-piperidinamines
US4219559A (en) * 1979-01-10 1980-08-26 Janssen Pharmaceutica N.V. N-Heterocyclyl-4-piperidinamines
PH23995A (en) * 1984-01-09 1990-02-09 Janssen Pharmaceutica Nv 4((bicycle heterocyclyl)-methyl and hetero)piperidines
US4695575A (en) * 1984-11-13 1987-09-22 Janssen Pharmaceutica, N.V. 4-[(bicycle heterocyclyl)-methyl and -hetero]-piperidines
AU1041599A (en) * 1997-11-13 1999-06-07 Jose Luis Castro Pineiro Therapeutic uses of triazolo-pyridazine derivatives

Also Published As

Publication number Publication date
AU3408999A (en) 1999-09-20
WO1999044596A3 (en) 2000-02-17
PL343435A1 (en) 2001-08-13
BR9907951A (en) 2001-01-30
HUP0101048A2 (en) 2001-10-28
BG104685A (en) 2001-04-30
NO20004431D0 (en) 2000-09-05
TR200002567T2 (en) 2000-11-21
WO1999044596A2 (en) 1999-09-10
EE200000482A (en) 2002-02-15
SK13082000A3 (en) 2001-03-12
EP1059922A2 (en) 2000-12-20
CN1292698A (en) 2001-04-25
IL138228A0 (en) 2001-10-31
HRP20000523A2 (en) 2001-02-28
KR20010032968A (en) 2001-04-25
JP2002505277A (en) 2002-02-19
CA2322164A1 (en) 1999-09-10

Similar Documents

Publication Publication Date Title
NO20004432L (en) Glysintransportinhibitorer
WO1999044596A3 (en) Glycine transport inhibitors
MXPA05002420A (en) Thiazole compounds for the treatment of neurodegenerative disorders.
DE60126980D1 (en) THERAPEUTIC AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF AMYLOIDOGENIC ILLNESSES
BG108860A (en) Bicyclic aminoacids, pharmaceutical composition based on them, and the administration thereof
DE60037139D1 (en) POLY-HYDROXYLATED AROMATIC COMPOUNDS FOR THE TREATMENT OF AMYLOIDOSIS AND ALPHA-SYNUCLEIN FIBRIL DISEASES
PT1259489E (en) AZAPOLICYLIC COMPOUNDS CONDENSED WITH ARYLOUS.
AP2004002952A0 (en) N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds.
MXPA04003245A (en) Hydroxypropylamines.
WO2001053457A3 (en) Vaccines against neurodegenerative disorders
ATE367387T1 (en) USE OF OXINDOL DERIVATIVES FOR THE TREATMENT OF DEMENTIA-RELATED DISEASES, ALZHEIMER'S DISEASE AND GLYCOGEN SYNTHASE KINASE-3-ASSOCIATED CONDITIONS
DE59900222D1 (en) USE OF HYPERFORIN AND HYPERFORIN-CONTAINING EXTRACTS FOR THE TREATMENT AND PROPHYLAXIS OF Dementia Diseases
DE60306503D1 (en) STATIN THERAPY FOR IMPROVING THE MAINTENANCE OF COGNITIVE FUNCTION
DE60231054D1 (en) Piperidin derivatives, process for their preparation and pharmaceutical composition for the treatment of Alzheimer's disease containing these derivatives
GR3032531T3 (en) Use of efaxoran and its derivatives for the production of drugs for treating neurodegenerative diseases
DE60204046D1 (en) N-HETEROCYCLYLHYDRAZIDE AS NEUROTROPHE MEDIUM
BR0116724A (en) Compound, method of treating a neurological disorder or neurodegenerative disease, method of treating pain, pharmaceutical composition, use of a compound, and processes for the preparation and synthesis of a compound
NO993126D0 (en) Use of benzoylalkyl-1,2,3,6-tetrahydropyridines
ATE347893T1 (en) TRIAZEPINE DERIVATIVES AS NEUROTROPIC AGENTS
DE602004019133D1 (en) USE OF 1,2-DIAZADIBENZOES, HAZAZULES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF DISEASES AND DISORDERS OF THE CENTRAL NERVOUS SYSTEM
DE602004019129D1 (en) USE OF 1-OXADIBENZOAE, HÜ AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF ILLNESSES AND
DE602004008796D1 (en) USE OF 1,3-DIAZADIBENZOES, hÜ AZULES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF DISEASES AND DISORDERS OF THE CENTRAL NERVOUS SYSTEM
EA200500382A1 (en) TIAZOLE CONNECTIONS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application